The vaccine market today is characterized by strong growth prospects, increased R&D activity and higher valuations. The market is growing at the rate of 16% and is expected to reach $21 Billion USD by 2010. The vaccines market is poised for growth inspite of increasing complexities and a dynamic market environment.

The PharmARC vaccine consulting team combines the cross-functional expertise across the organization to provide innovative solutions in the areas of:

Vaccine Assessments
Vaccine Market and Opportunity Assessment
Pipeline Analysis
Review and Monitoring of Analyst Reports
Vaccine Tender Monitoring Tool (VTMT): A web-based tool that provides details on tender    schedules, management, budgeting and reports which would enable the pharma company to be    on-time for tender submissions, provide a winning quote and thus be ahead of competitors.

Key Consulting Services include

1. KOL Identification and Profiling
Identification, profiling, segmentation and ranking of Key Opinion Leaders (KOLs) and Rising Stars
Providing web or excel-based, user-friendly tools with regular updates

2. Vaccine Forecasts
Sales/Epi-based Demand Forecasts with user-friendly, event-based forecasting tools
Population-based Consumption Forecasts involving scenario-based, user-friendly forecasting tools

3. Competitive Intelligence
Weekly/Monthly/Quarterly Newsletters
Company Intelligence Reports

4. Primary Market Research
Potential Marketing Partner Identification
KOL Identification
Target Product Profile (TPP) Testing

5. Data Analytics
Extracting, cleaning and analyzing data available on public domain
Analyzing internal data on sales, prescription, and promotional spend

PharmARC's vaccine specific capabilities enable clients to provide end-to-end solutions for guidelines, recommendations, immunization schedules and potential groups for vaccination.

The Vaccines Team
Our specialized vaccine consulting team has first-hand experience of the vaccines market. The team comprises of members with product management experience who have handled a range of vaccines portfolios. The team has extensive experience in epidemiology, competitive intelligence and forecasting.

The ability to map the future landscape of immunization policies worldwide continues to help us provide invaluable insights to clients facing high levels of uncertainty, especially in developing countries.

Why PharmARC?
We create innovative vaccine-specific methodologies to assess and quantify potential risk groups
Develop event-based forecast tools which help test internal assumptions and ultimately serve to
    build consensus across commercial and development teams
Understand, build and project the vaccine adoption lifecycle across the emerging market countries